DNA repair and breast carcinoma susceptibility in women
โ Scribed by Juan M. Ramos; Abigail Ruiz; Rivka Colen; Ivette D. Lopez; Lawrence Grossman; Jaime L. Matta
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 126 KB
- Volume
- 100
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
BACKGROUND
Breast carcinoma is the most common cancer and the second leading cause of cancerโrelated deaths among women. The disease represents approximately 31% of all cancers in Puerto Rican women. Several DNA repair pathways are involved in preventing carcinogenesis. The current study evaluated the hypothesis that a reduced DNA repair capacity (DRC) is a susceptibility factor for breast carcinoma.
METHODS
A retrospective caseโcontrol clinical study was performed to compare ageโmatched DRC in 33 women with histopathologically confirmed breast carcinoma (cases) and 47 cancerโfree women (controls). DRC was measured using a host cell reactivation assay with a luciferase reporter gene and then transfected into human peripheral lymphocytes. A questionnaire was used to solicit breast carcinoma risk factors.
RESULTS
Women with breast carcinoma had a mean DRC of 5.6% ยฑ 0.5 standard error of the mean (SEM). Cancer cases had a 36% reduction (P < 0.001) in DRC when compared with the control group (DRC = 8.7% ยฑ 0.7 SEM). Younger participants with breast carcinoma were found to have a more significant reduction in DRC when compared with ageโmatched controls. Family (odds ratio [OR] = 4.1), maternal lineage (OR = 5.5), and maternal (OR = 12.4) history of breast carcinoma were found to be the only statistically significant (P < 0.05) risk factors associated with the disease.
CONCLUSIONS
The findings supported the hypothesis that a low DRC is a susceptibility factor for breast carcinoma. A 1% decrease in DRC corresponded to a 22% increase in breast carcinoma risk. To the authors' knowledge, the current study was the first to directly determine the DRC of women with breast carcinoma. Because DRC is an independent risk factor for breast carcinoma, the DRC of women may be a useful marker in predicting susceptibility. Cancer 2004;100:1352โ7. ยฉ 2004 American Cancer Society.
๐ SIMILAR VOLUMES
Breast carcinoma is the most common cancer in women in the U.S. and the second leading cause of cancer death in women. Furthermore, there are racial differences in breast carcinoma incidence, mortality, and survival rates. Social and economic factors within racial/ethnic groups are being examined as
## Abstract DNA repair is a complicated biological process, consisting of several distinct pathways, that plays a fundamental role in the maintenance of genomic integrity. The very important field of DNA repair and cancer risk has developed rapidly in the past decades. In this review of selected pu
## Background: Breast carcinoma and differentiated thyroid carcinoma(the most common endocrine malignancy) occur predominantly in women. an association between the two tumors has been suggested by some investigators, but the potential impact of treatment of one of these diseases on the development
A significant disparity in mortality rates exists between black and white patients with breast carcinoma. This study was designed to compare breast carcinoma tumor characteristics by race and to examine the possible reasons for these differences. ## METHODS. Female patients with an initial diagnosi
## Abstract ## BACKGROUND Many young patients with breast carcinoma have not started, or completed, their desired families. How childbearing after a diagnosis of breast carcinoma affects survival is of importance to these women and their families. The authors measured relative mortality among youn